Trametinib + DABRAFENIB

5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Trametinib + DABRAFENIB
Treatment and conditionWhere it standsTrials
Trametinib + DABRAFENIB for ameloblastomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Trametinib + DABRAFENIB for erdheim-chester diseasePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Trametinib + DABRAFENIB for gliomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Trametinib + DABRAFENIB for pancreatic diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Trametinib + DABRAFENIB for thyroid carcinoma, anaplasticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1